Cumulative and interval summary of adverse reactions (Pfizer – 2022)
Reference: Pfizer. (2022). Cumulative and interval summary tabulation of serious and non-serious adverse reactions from post-marketing data sources BNT162B2. Summary: The document presents a comprehensive analysis of cumulative and interval data on serious and non-serious adverse reactions associated with the BNT162B2 vaccine up to June 18, 2022. It details a total of 1,485,027 cases cumulatively, […]